Wegovy Oral Pill Now Available at Pharmacies
Sydney, 12 January 2026 – The weight loss medication Wegovy is now available as an oral pill at pharmacies across the country, providing patients with a convenient alternative to injections. The pill, containing the active ingredient semaglutide, has been approved by the Food and Drug Administration and offers similar effectiveness and safety to the injectable version.
Availability and How It Works
Starting doses of the Wegovy pill arrived at pharmacies on Monday, with higher doses expected by the end of the week. Patients can fill prescriptions for the oral form, which must be taken on an empty stomach, followed by a 30-minute wait before eating or drinking anything else to ensure proper absorption. Dr. Scott Isaacs, past president of the American Association of Clinical Endocrinology, advises patients to follow directions carefully, noting that improper use could render it ineffective or expensive.
Affordability remains a key barrier, with cash prices set at A$149 per month for starting doses and A$299 for higher doses. For insured patients, copays could be as low as A$25 per month, based on the list price of around A$1,400 per month, matching the injectable version. Insurance coverage for weight loss drugs has become more restrictive in 2025, according to a GoodRx analysis.
The pill was approved by the FDA on 22 December, with a competing obesity pill from Eli Lilly expected later this year. Patients with insurance may benefit from these lower copays, while those without could face higher out-of-pocket costs.
Key Facts and Pricing
| Aspect | Details |
|---|---|
| Active Ingredient | Semaglutide |
| FDA Approval Date | 22 December |
| Cash Price (Starting Dose) | A$149 per month |
| Cash Price (Higher Dose) | A$299 per month |
| List Price (Insurance) | A$1,400 per month |
| Potential Copay | As low as A$25 per month |
Frequently Asked Questions
What is the main difference between the Wegovy pill and injection?
The pill is taken orally once daily on an empty stomach, while the injection is weekly. Both contain semaglutide and have similar safety and effectiveness, but the pill requires strict timing to avoid interference from food or coffee.
Who can prescribe Wegovy?
Healthcare providers can prescribe it for eligible patients with obesity or overweight conditions, often alongside lifestyle changes like diet and exercise.
Are there side effects?
Common side effects include nausea, vomiting, and gastrointestinal issues. Patients should consult their doctor for personalised advice.